BIOS Stock Chart & Historical Trading Data $BIOS Updated:

New Post Public Reply Private Reply Replies (0) Message Board
stockcharts
316
BIOS Stock Chart & Historical Trading Data $BIOS Updated: 02-07-2017
Last Trade: 2/7/2017
Last 1.70   
Open 1.72
Previous Close 1.70
Day High / Low 1.76 / 1.67
Year High / Low 3.43 / 0.98
Volume 1,990,144
Projected Volume 1990144 (89%)
# of Trades / Projected 6,322 / 6,322
Dividend / Yield - / 0.00%
Abnormal Activity NONE
Abnormal Volume NO
Gap NONE
Candle BEARISH
Volatility Today HIGH
Volatility Yesterday HIGH
Price Relativity
From 40 Day High 95%
From 80 Day High 55%
From 150 Day High 51%
From 40 Day Low 167%
From 80 Day Low 167%
From 150 Day Low 167%
Pivot Analysis
Price Pivot $ 1.71
Day Resistance 1 $ 1.75
Day Support 1 $ 1.66
Day Resistance 2 $ 1.80
Day Support 2 $ 1.62
Consolidations
Short Term YES
Medium Term YES
Long Term YES
Volume Indicators
20 Day Avg Vol 2,243,041
Today / 20 Day Avg Vol BELOW
150 Day Avg Vol 1,352,281
Today / 150 Day Avg Vol ABOVE
Abnormal Volume NO
William Volume Accumulation bullish
Volume Price Trend bullish
Momentum Indicators
10 Day Trend bullish
40 Day Trend bullish
100 Day Trend bearish
Stochastics bearish
RSI neutral
MACD bullish
Moving Average Indictors
15 Day Trend bullish
45 Day Trend bullish
100 Day Trend bearish
Mid Term Moving Average Crossover NONE
Long Term Moving Average Crossover NONE
Volatility Indicators
Abnormal Activity Today? NONE
Volatility Index Today HIGH
Volatility Index Yesterday HIGH
10 Day Volatility DECREASING
20 Day Volatility DECREASING
40 Day Volatility DECREASING

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Caldolor®: A Breakthrough in Opioid-Sparing Pain Relief for Seniors

Updated Category News Views 183

Revolutionizing Pain Management for Older Adults This comprehensive analysis reveals groundbreaking findings about Caldolor® (intravenous ibuprofen) and its effectiveness in managing pain for older adults. As the population ages, the need for safer alternatives for pain relief has significantly increased. Recent studies showcase a marked reduction in opioid consumption...

Continue Reading
Certara Stock Faces Challenges as it Hits a 52-Week Low

Updated Category News Views 120

Certara's Stock Market Performance Certara Inc. (NASDAQ: CERT), recognized as a frontrunner in biosimulation technology, has recently seen its stock price fall to a concerning 52-week low of $10.35. This price decline highlights a notable shift from its previous valuation, indicating a tumultuous time for shareholders. Over the last year, Certara's stock has experienced a...

Continue Reading
Urgent Reminder for WM Technology Shareholders on Lead Plaintiff Deadline

Updated Category News Views 159

Important Information for WM Technology Shareholders The Gross Law Firm is reaching out to shareholders of WM Technology, Inc. (NASDAQ: MAPS). This notice serves as a crucial reminder regarding the upcoming deadline for appointing a lead plaintiff in the class action lawsuit involving the company. Who Should Contact the Gross Law Firm? If you have purchased shares of MAPS...

Continue Reading
Nebraska Medicine Enhances Cancer Services with Expansion

Updated Category News Views 82

Nebraska Medicine Strengthens Cancer Care Network Nebraska Medicine is making significant strides in enhancing cancer care with the introduction of its new facility, Nebraska Medicine Fred & Pamela Buffett Cancer Center – Kearney. This expansion aims to serve communities across various regions, and it heralds an exciting phase for cancer treatment and research in the...

Continue Reading
Sunshine Silver's IPO: A Spotlight on Silver's Future

Updated Category News Views 8

Sunshine Silver Steps into the Spotlight Ah, the thrill of a fresh IPO. Sunshine Silver Mining & Refining Company, rolling under the ticker SSMR, has announced its initial public offering price—$13.50 a share, with 20 million shares up for grabs. This development has sure piqued the interest of traders eyeing some silver lining. The Figures That Matter Alright, let’s...

Continue Reading